REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

Share Price Information for Jaywing (JWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.10
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.10 (3.226%)
Open: 3.15
High: 3.15
Low: 3.15
Prev. Close: 3.15
JWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Jaywing plc

4 Mar 2024 15:56

RNS Number : 5217F
Jaywing PLC
04 March 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Lord Ashcroft KCMG PC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Jaywing plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

4th March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

 

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

27,919,737

29.9

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

 

 

 

 

 

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

4th March 2024

Contact name:

Philip Osborne

Telephone number*:

+501 227 7178

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSSAFILELSELD
Date   Source Headline
10th Dec 202011:30 amRNSDirector/PDMR Shareholding
10th Dec 20207:00 amRNSHalf-year Report
26th Nov 20207:00 amRNSFinal Results
21st Oct 20207:00 amRNSExercise and completion of put option
29th Sep 20201:37 pmRNSResult of AGM
4th Sep 202010:05 amRNSNotice of AGM
26th Aug 20207:00 amRNSAppointment of CFO & Trading Update
29th Jul 20208:58 amRNSHolding(s) in Company
21st Apr 20207:00 amRNSDirectorate Change
26th Mar 20207:00 amRNSDirectorate Change
24th Mar 20207:00 amRNSDirectorate Change
18th Mar 20205:25 pmRNSAIM Rule 17 Notification
27th Jan 20207:00 amRNSDirectorate Change
20th Dec 20197:00 amRNSHalf-year Report
8th Nov 20199:10 amRNSHolding(s) in Company
8th Oct 20193:20 pmRNSNotice of GM
2nd Oct 20192:06 pmRNSPublication of Notice of AGM
2nd Oct 20197:00 amRNSFurther re. trading update & related party
30th Sep 20193:44 pmRNSResult of AGM
30th Sep 20197:00 amRNSAnnual Financial Report
26th Sep 20192:06 pmRNSSecond Price Monitoring Extn
26th Sep 20192:00 pmRNSPrice Monitoring Extension
13th Sep 201911:05 amRNSSecond Price Monitoring Extn
13th Sep 201911:00 amRNSPrice Monitoring Extension
12th Sep 20194:40 pmRNSSecond Price Monitoring Extn
12th Sep 20194:35 pmRNSPrice Monitoring Extension
11th Sep 20192:05 pmRNSSecond Price Monitoring Extn
11th Sep 20192:00 pmRNSPrice Monitoring Extension
30th Aug 20197:00 amRNSFurther re. trading update and results
6th Aug 20191:30 pmRNSAIM Rule 17 Notification
18th Jul 20195:07 pmRNSHolding(s) in Company
10th Jul 201911:37 amRNSTrading Statement
13th May 20197:00 amRNSAwards
2nd May 20197:00 amRNSTrading Statement
19th Feb 201911:32 amRNSHolding(s) in Company
10th Jan 20197:00 amRNSCompletion of Disposal
20th Nov 20187:01 amRNSHalf-year Report
20th Nov 20187:00 amRNSDisposal
29th Oct 20184:10 pmRNSHolding(s) in Company
11th Sep 20181:46 pmRNSResult of AGM and Trading Update
29th Aug 20187:00 amRNSClient Wins
16th Aug 20187:00 amRNSAnnual Financial Report
10th Jul 20189:41 amRNSFinal Results - Replacement
10th Jul 20187:00 amRNSFinal Results
25th Apr 20187:00 amRNSTrading Statement and Full Year Results Date
28th Mar 20184:03 pmRNSHolding(s) in Company
16th Mar 201810:28 amRNSHolding(s) in Company
15th Mar 20188:18 amRNSDirector/PDMR Shareholding
14th Mar 201812:06 pmRNSResult of General Meeting
27th Feb 20183:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.